
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1037 | 1037 | 967 | 1008 | - | - |
Fund Return | 3.75% | 3.75% | -3.27% | 0.26% | - | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0171289225 | 948.18M | -4.43 | 9.24 | 5.90 | ||
Global Allocation Fund X2 Use | 833.45M | -1.21 | 4.15 | 6.10 | ||
LU0408221512 | 1.26B | -1.63 | 2.38 | 4.30 | ||
LU0523293024 | 1.11B | -1.45 | 3.16 | 5.09 | ||
BlackRock Global Allocation EUR A2 | 6.43B | -1.63 | 2.39 | 4.31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 58.96B | -2.42 | 9.05 | 6.45 | ||
Invesco JapEqAdvantage C EUR H AccE | 58.96B | -2.18 | 10.05 | 7.30 | ||
LU1841614867 | 246.43M | -5.55 | 8.31 | - | ||
LU1482751903 | 405.58M | -5.40 | 9.27 | - | ||
Morgan Stanley Global Brands CH | 19.85B | 0.83 | 0.74 | 6.17 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.44 | 754.35 | +3.00% | |
AbbVie | US00287Y1091 | 6.08 | 179.10 | +2.31% | |
Boston Scientific | US1011371077 | 4.84 | 94.27 | +0.64% | |
Abbott Labs | US0028241000 | 4.48 | 127.96 | +0.85% | |
Intuitive Surgical | US46120E6023 | 4.45 | 490.13 | -0.70% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review